{
    "success": true,
    "data": {
        "leverage": true,
        "derivatives": true,
        "swaps": false,
        "inverse": true,
        "replication_method": "synthetic",
        "ucits": true,
        "type": "ETP",
        "complex_factors": [
            "Leverage (-3x daily)",
            "Inverse strategy",
            "Derivatives (futures contracts) are integral to objective",
            "Daily reset with compounding effect",
            "Structured as a collateralised debt security",
            "Comprehension alert present in KID",
            "Underlying index (Bund Rolling Future Index) relies on futures contracts and their 'rolling' effects, which are not easily understood by average retail investors."
        ],
        "classification": "complex",
        "supporting_data": "The product is a 'WisdomTree Bund 10Y 3x Daily Short', classified as a 'collateralised debt security' (ETP), not a traditional UCITS ETF holding underlying assets physically. It explicitly states 'You are about to purchase a product that is not simple and may be difficult to understand', which is a mandatory comprehension alert for complex products under MiFID II (Rule 7). The product aims to provide a '-3 times the daily performance' of the 'Bund Rolling Future Index (BNSXFRXE)', indicating significant leverage and an inverse strategy. Its reliance on 'Bunds futures contracts' for its investment objective means derivatives are integral to its strategy (Rule 2). The KiiD highlights the 'compounding effect' due to the daily reset of the leverage factor, explaining that 'the more volatile the performance of the Index, the more the performance of the product will deviate' from the leveraged index return over periods longer than one day. This specific feature, along with the 'rolling' of futures contracts, introduces risks and payoff complexities (e.g., contango/backwardation, roll costs) that are difficult for an average retail investor to understand (Rule 4). The target investor is defined as 'informed retail investors' with 'specific knowledge or experience of investing in similar products and in financial markets', contradicting the 'basic knowledge' premise for non-complex products. Although it is UCITS eligible, its structure and features clearly overturn the presumption of non-complexity (Rule 1). The product's classification as a 'collateralised debt security' issued by a 'special purpose company' further indicates a synthetic, structured product nature, implicitly involving embedded derivatives for performance replication. ESMA guidelines (CESR/09-295, Annex I) clearly list 'MiFID-scope derivatives (items 4-10 of Section C of the Annex to MiFID)' and 'Other securities giving the right to acquire or sell a transferable security or giving rise to a cash settlement determined by reference to transferable securities, currencies, interest rates or yields, commodities or other indices or measure (Article 4(1)(18)(c) of MiFID Level 1 Directive)' as 'ALWAYS COMPLEX'. This product's objective and structure fall under these categories. Furthermore, significant leverage directly contributes to complexity (Rule 5). The 7 out of 7 risk rating in the KID also reflects the high-risk nature tied to its complex mechanisms. All these factors combine to make this ETP definitively complex."
    }
}